ArticlePathology oncology research : POR2019

Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program.

Gergely Varga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.